Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares traded.
Anthera Pharmaceuticals Trading Down 100.0%
Anthera Pharmaceuticals Company Profile
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Featured Stories
- Five stocks we like better than Anthera Pharmaceuticals
- What Investors Need to Know to Beat the Market
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- Investing in the High PE Growth Stocks
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
